Nuvectis Pharma Current Assets

The latest current assets for NVCT is $22M as of June 2026. That compares with $27M in the prior-year period — down 17.1% year over year. Investors often review this figure alongside Nuvectis Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVCT's current assets moved from $27M to $22M — a 17.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nuvectis Pharma's operating scale or balance-sheet position.

A current assets figure of $22M for NVCT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVCT's current assets ($22M), review year-over-year change from $27M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.